Clinical trial
Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic…
NCT00480506 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00480506 |
|---|---|
| Title | Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major |
| Official title | Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Tehran University of Medical Sciences |
| Status | Completed |
| Study type | Observational |
| Conditions | Thalassemia Major |
| Enrollment | 40 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | May 31, 2007 |
| Last update posted | Feb 23, 2012 |
| Countries | Iran, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: